This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Walter Strapps, PhD
Chief Scientific Officer at Liberate Bio


Dr. Walter R. Strapps is the Chief Scientific Officer of Liberate Bio, a seed stage company in the lipid nano-particle space. He was the co-founder and CEO of Carver Biosciences, Inc. His past roles include Chief Scientific Officer at Gemini Therapeutics where he led all aspects of pre-clinical research, PK and biomarkers for Gemini’s clinical trials. Before joining Gemini, Dr. Strapps was Vice President of Discovery at Intellia Therapeutics, leading programs across a range of therapeutic areas. Dr. Strapps held previous roles in RNA Therapeutics at Merck & Co., Inc in Pennsylvania and California and at Sirna Therapeutics and Sentigen Biosciences in Colorado and New York respectively. Dr. Strapps obtained his doctorate, M.A. and M.Phil. degrees from Columbia University and B.Sc. from McGill University. Dr. Strapps serves on the board of Sona Nanotech. Walter was born and raised in Nova Scotia and is a proud Bluenoser.

Agenda Sessions

  • RAPTOR: A High Throughput Platform for Screening LNPs in Primates